Pneumocystis pneumonia associated with human immunodeficiency virus infection without elevated (1 → 3)-β-D glucan: A
Takahiro Kamada1, Kenjiro Furuta1, Hiromi Tomioka1
1Department of Respiratory Medicine, Kobe City Medical Center West Hospital, Japan.
Abstract:
Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii is one of the most common opportunistic infections in immunosuppressed patients, particularly in patients with acquired immunodeficiency syndrome (AIDS). (1 → 3)-β-D-glucan is a component of the cell wall of P. jirovecii and other fungi such as Candida sp., Aspergillus sp. and Histoplasma sp. The measurement of serum (1 → 3)-β-D-glucan has been reported to be a highly sensitive test for PCP related to human immunodeficiency virus (HIV-PCP). We report a case of HIV-PCP not associated with elevated serum (1 → 3)-β-D glucan and highlight how HIV-PCP cannot be completely ruled out if (1 → 3)-β-D glucan is negative.
Insights
Pneumocystis pneumonia (PCP) in HIV patients can occur even with normal serum (1→3)-β-D-glucan levels. This finding emphasizes that a negative test does not rule out this opportunistic infection.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunocompromised Host Infections
Background:
- Pneumocystis pneumonia (PCP) is a significant opportunistic infection in immunosuppressed individuals, especially those with acquired immunodeficiency syndrome (AIDS).
- Serum (1→3)-β-D-glucan is a biomarker derived from the cell wall of Pneumocystis jirovecii, a fungus responsible for PCP.
- Elevated serum (1→3)-β-D-glucan is generally considered a sensitive indicator for human immunodeficiency virus-associated PCP (HIV-PCP).
Observation:
- This report details a specific case of HIV-PCP.
- In this particular case, serum (1→3)-β-D-glucan levels were not elevated despite the presence of PCP.
Findings:
- The case demonstrates that a negative serum (1→3)-β-D-glucan assay does not exclude the diagnosis of HIV-PCP.
- This challenges the assumption of high sensitivity in all HIV-PCP cases.
Implications:
- Clinicians should maintain a high index of suspicion for PCP in at-risk patients, even with negative biomarker results.
- Diagnostic strategies for PCP in immunocompromised patients may require a multi-faceted approach beyond single biomarker testing.
- Further research is warranted to understand the reasons for negative biomarker results in confirmed PCP cases.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Atypical Pneumonia
Pneumonia II: Pathophysiology
Cytomegalovirus Disease


